MedTrace Logo

Progesterone Supplementation in Threatened Abortion

NCT03930212 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2023-07-18

No results posted yet for this study

Summary

To decide whether progesterone supplementation in threatened abortion is a sound practice.

Conditions

  • Threatened Abortion
  • Progesterone Resistance

Interventions

DRUG

Progesterone

received rectal progesterone suppositories 400 mg once daily

DRUG

Placebos

received placebo suppositories rectally once daily.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03930212 on ClinicalTrials.gov